Treating Parents With ADHD and Their Young Children Via Telehealth: A Hybrid Type I Effectiveness-Implementation Trial
Key facts
- Who runs it
- University of Maryland, College Park
- Where
- College Park, United StatesSee the site
- Trial code
- Status
- Completed
- Phase
- Phase 3
- People taking part
- 269 people enrolled
- Started
- 6 Aug 2020
- Ended
- 31 Jul 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Behavioral Parent Training
- Extended release mixed amphetamine salts (MAS)
- Record updated
- 16 September 2026
Who can take part
- Age
- 3 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 19 criteriaShow less
Other criteria
- Child Inclusion Criteria:
- Be at least 3 years old and no more than 8 years old
- ADHD medication naive or have not had an adequate trial of stimulant medications
- Have ≥5 inactivity or ≥5 hyperactivity symptoms rated as 1 or 2 on the Vanderbilt
- Have a CGI-S-ADHD rating ≥4 and <7; Child Exclusion Criteria:
- Severe ADHD (CGI-S-ADHD score of greater than 6); Parent Inclusion Criteria:
- Be at least 21 years old and English-speaking
- Meet full DSM-5 criteria for ADHD (any subtype)
- Have findings on physical examination, laboratory studies, vital signs, and electrocardiogram judged to be normal for age with no contraindications for stimulant medication
- Have pulse and blood pressure (BP) within 95% of age and gender mean
- Women of childbearing potential agree to use a medically accepted contraception method consistently
- Parents with common comorbid conditions will be included provided that: (a) they do not report active suicidal ideation with intent (i.e. Beck Depression Inventory (BDI)-II score of 2 or 3 to Q9 which assesses suicidal thoughts); and (b) if receiving an antidepressant medication, their medication is well-tolerated, has not changed within 30 days, and the prescribing physician approves of their participation in the study
- Must have regular access to a computer or phone that can be used to deliver the behavioral parent training; Parent Exclusion Criteria:
- History of allergic or other severe negative reactions to study medications
- Substance abuse in the past 3 months, or a positive baseline urinary toxic screen that is not explained by a time-limited medical circumstance
- Current bipolar disorder, schizophrenia, psychoses, or other primary psychiatric disorder requiring other immediate treatment
- History of chronic/acute medical disorder for which stimulant therapy would be contraindicated (e.g., glaucoma, hypertension)
- Stimulant medication for ADHD in the past 30 days
- Is pregnant
Where in United States
- University of MarylandCollege Park, United States
About the trial
What the trial wants to find out
This study will compare the effectiveness of combined parental stimulant medication and behavioral parent training (BPT) versus BPT alone on child ADHD-related impairment (primary outcome), child ADHD and externalizing symptoms, time to child stimulant prescription (secondary child outcomes) and parental ADHD impairment, parental ADHD symptoms, parenting, and BPT engagement (parental outcomes/target mechanisms). This study will also assess the care delivery context and develop an implementation approach for treatment of families with a parent with ADHD and a child with elevated ADHD symptoms via telehealth in primary care sites providing pediatric care.
The 2 groups in the trial
- Parent Stimulant Medication + Child Treatment StrategyTreatment being tested
Parent stimulant medication first followed by a child treatment strategy consisting of behavioral parent training followed by a recommendation for child stimulant medication to the primary care provider if the child remains impaired.
Treatment: Behavioral Parent Training and Extended release mixed amphetamine salts (MAS)
- Child Treatment StrategyExisting treatment, for comparison
Child treatment strategy consisting of behavioral parent training followed by a recommendation for child stimulant medication to the primary care provider if the child remains impaired. In this arm, parents do not receive stimulant medication before behavioral parent training.
Treatment: Behavioral Parent Training
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- 2/2 Treating Mothers With ADHD and Their Young Children Via Telehealth: A Hybrid Type I Effectiveness-Implementation Trial
- Publications
- Treating parents with ADHD and their children (TPAC): a hybrid effectiveness-implementation, randomized controlled trial.Journal of child psychology and psychiatry, and allied disciplines, 2026
- Screening for parent and child ADHD in urban pediatric primary care: pilot implementation and stakeholder perspectives.BMC pediatrics, 2023
- Record updated
- 16 September 2026